A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels

被引:23
|
作者
Espeseth, Amy S.
Huang, Qian
Gates, Adam
Xu, Min
Yu, Yuanjiang
Simon, Adam J.
Shi, Xiao-Ping
Zhang, Xiaohua
Hodor, Paul
Stone, David J.
Burchard, Julja
Cavet, Guy
Bartz, Steven
Linsley, Peter
Ray, William J.
Hazuda, Daria
机构
[1] Merck Res Labs, Virus & Cell Biol, West Point, PA 19486 USA
[2] Rosetta Inpharmat, Dept Biol, Seattle, WA 98019 USA
[3] Rosetta Inpharmat, Dept Mol Profiling, Seattle, WA 98019 USA
[4] Merck Res Labs, Mol Profiling, West Point, PA 19486 USA
[5] Merck Res Labs, Biometr Res, West Point, PA 19486 USA
[6] Merck Res Labs, Alzheimers Res, West Point, PA 19486 USA
[7] Merck Res Labs, Dept Mol & Cellular Technol, West Point, PA 19486 USA
关键词
Alzheimer's; BACE1; regulation; PPIL2; hCyp-60; siRNA screen;
D O I
10.1016/j.mcn.2006.07.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Proteolysis of beta-amyloid precursor protein (APP) into amyloid beta peptide (A beta) by beta- and gamma-secretases is a critical step in the pathogenesis of Alzheimer's Disease (AD), but the pathways regulating secretases are not fully characterized. Ubiquitinylation, which is dysregulated in AD, may affect APP processing. Here, we describe a screen for APP processing modulators using an siRNA library targeting 532 predicted ubiquitin ligases. Seven siRNA pools diminished A beta production. Of these, siRNAs targeting PPIL2 (hCyp-60) suppressed beta-site cleavage. Knockdown of PPIL2 mRNA decreased BACE1 mRNA, while overexpression of PPIL2 cDNA enhanced BACE1 mRNA levels. Microarray analysis of PPIL2 or BACE1 knockdown indicated that genes affected by BACE1 knockdown are a subset of those dependent upon PPIL2; suggesting that BACE1 expression is downstream of PPIL2. The association of PPIL2 with BACE expression and its requirement for AP production suggests new approaches to discover disease modifiying agents for AD. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [1] RNAi inhibition of BACE1 and BACE2 expression in HEK293-APPSWE/LON cells identifies a dominant role for BACE1 in APP processing
    Chen, X
    Wang, LY
    Kennedy, ME
    NEUROBIOLOGY OF AGING, 2004, 25 : S532 - S532
  • [2] Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1
    Zhang, Mingming
    Deng, Yu
    Luo, Yawen
    Zhang, Shuting
    Zou, Haiyan
    Cai, Fang
    Wada, Keiji
    Song, Weihong
    JOURNAL OF NEUROCHEMISTRY, 2012, 120 (06) : 1129 - 1138
  • [3] Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: Blockage by curcumin
    Lin, Raozhou
    Chen, Xiaohong
    Li, Wenming
    Han, Yifan
    Liu, Peiqing
    Pi, Rongbiao
    NEUROSCIENCE LETTERS, 2008, 440 (03) : 344 - 347
  • [4] Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse
    Orejana, Lourdes
    Barros-Minones, Lucia
    Jordan, Joaquin
    Cedazo-Minguez, Angel
    Tordera, Rosa M.
    Aguirre, Norberto
    Puerta, Elena
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2015, 70 (06): : 675 - 685
  • [5] Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis
    Kamini Kaushal
    Eun-Jung Kim
    Apoorvi Tyagi
    Janardhan Keshav Karapurkar
    Saba Haq
    Han-Sung Jung
    Kye-Seong Kim
    Suresh Ramakrishna
    Cell Death & Differentiation, 2022, 29 : 1689 - 1704
  • [6] Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis
    Kaushal, Kamini
    Kim, Eun-Jung
    Tyagi, Apoorvi
    Karapurkar, Janardhan Keshav
    Haq, Saba
    Jung, Han-Sung
    Kim, Kye-Seong
    Ramakrishna, Suresh
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (09): : 1689 - 1704
  • [7] Re: Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2016, 195 (04): : 1171 - 1171
  • [8] A genome-wide CRISPR screen identifies USP1 as a novel regulator of the mammalian circadian clock
    Hu, Ying
    Li, Xin
    Zhang, Jing
    Liu, Dengfeng
    Lu, Renbin
    Li, Jia-Da
    FEBS JOURNAL, 2024, 291 (03) : 445 - 457
  • [9] Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response
    Backman, Joshua D.
    O'Connell, Jeffrey R.
    Tanner, Keith
    Peer, Cody J.
    Figg, William D.
    Spencer, Shawn D.
    Mitchell, Braxton D.
    Shuldiner, Alan R.
    Yerges-Armstrong, Laura M.
    Horenstein, Richard B.
    Lewis, Joshua P.
    PHARMACOGENETICS AND GENOMICS, 2017, 27 (04): : 159 - 163
  • [10] Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants
    Damotte, Vincent
    van der Lee, Sven J.
    Chouraki, Vincent
    Grenier-Boley, Benjamin
    Simino, Jeannette
    Adams, Hieab
    Tosto, Giuseppe
    White, Charles
    Terzikhan, Natalie
    Cruchaga, Carlos
    Knol, Maria J.
    Li, Shuo
    Schraen, Susanna
    Grove, Megan L.
    Satizabal, Claudia
    Amin, Najaf
    Berr, Claudine
    Younkin, Steven
    Gottesman, Rebecca F.
    Buee, Luc
    Beiser, Alexa
    Knopman, David S.
    Uitterlinden, Andre
    DeCarli, Charles
    Bressler, Jan
    DeStefano, Anita
    Dartigues, Jean-Francois
    Yang, Qiong
    Boerwinkle, Eric
    Tzourio, Christophe
    Fornage, Myriam
    Ikram, M. Arfan
    Amouyel, Philippe
    de Jager, Phil
    Reitz, Christiane
    Mosley, Thomas H.
    Lambert, Jean-Charles
    Seshadri, Sudha
    van Duijn, Cornelia M.
    ALZHEIMERS & DEMENTIA, 2021, 17 (10) : 1663 - 1674